Ovarian Neoplasms

3 researchers across 2 institutions

3 Researchers
2 Institutions
0 Grant PIs
1 High Impact

Research in ovarian neoplasms investigates the fundamental biological processes that drive the development and progression of ovarian cancers. Studies examine the molecular mechanisms underlying tumor initiation and growth, focusing on cellular signaling pathways, genetic mutations, and the role of mitochondria in cellular function and dysfunction. Investigations also explore how diet and metabolism influence cancer development and progression, employing various experimental models, including animal models, to understand disease mechanisms. Furthermore, this area encompasses research into the detection and diagnosis of ovarian cancers, including the application of artificial intelligence to improve diagnostic accuracy.

This research holds significant relevance for Arkansas by addressing a critical public health concern. Ovarian cancer disproportionately affects women, and understanding its mechanisms can lead to improved prevention, early detection, and treatment strategies tailored to the needs of the state's population. By advancing knowledge in this field, the research aims to reduce the burden of this disease within Arkansas and contribute to better health outcomes for its residents.

This research area draws upon expertise in disease mechanisms, cancer cell biology, mitochondrial function, receptor signaling, and metabolic studies. It also benefits from collaborations in areas such as artificial intelligence for cancer detection and the use of animal models for disease study. Engagement across multiple institutions in Arkansas fosters a comprehensive approach to tackling the complexities of ovarian neoplasms.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Naveena Singh University of Arkansas – Fort Smith 64 16,943 High Impact
Nadine Hempel UAMS 39 4,959
Danny Baxter UAMS 1 13

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
9,506 works in 2025
+5.0% CAGR 2018–2025
Leadership concentration
5.2% held by global top 5 institutions
Fragmented HHI 20
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 3,003
  2. 2 Memorial Sloan Kettering Cancer Center 2,486
  3. 3 Harvard University 2,181
  4. 4 Massachusetts General Hospital 1,800
  5. 5 Brigham and Women's Hospital 1,479
Browse All 3 Researchers in Directory